BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 14, Issue 22
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis
Copyright: ©Author(s) 2026.
World J Clin Cases. Aug 6, 2026; 14(22): 121062
Published online Aug 6, 2026. doi: 10.12998/wjcc.121062
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 The association between irritable bowel syndrome and colorectal cancer literature search (the PRISMA chart).
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 The conditions of patients with irritable bowel syndrome and the control group. A: Colorectal cancer (CRC) in irritable bowel syndrome (IBS) and control subjects; B: CRC in IBS and control subjects (no heterogeneity). IBS: Irritable bowel syndrome.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Colorectal cancer in irritable bowel syndrome and control subjects, risk ratios. IBS: Irritable bowel syndrome.
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.